← Back to Search

Active Direct electrical stimulation (DES) for Epilepsy

N/A
Recruiting
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age range between 18 and 65
Major depressive disorder (MDD) in a current major depressive episode diagnosed with the Mini-International Neuropsychiatric Interview (MINI)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 minutes
Awards & highlights

Study Summary

This trial aims to show that video-based measures of audio and facial behaviors can provide an objective, continuous measure of internal mood.

Who is the study for?
This trial is for adults aged 18-65 with Major Depressive Disorder currently experiencing a depressive episode. Participants must understand the study and consent independently, without medical or surgical reasons preventing electrode implantation. It's not suitable for those with diffuse epilepsy affecting multiple brain lobes.Check my eligibility
What is being tested?
The study tests if audio-facial behaviors captured on video can reliably indicate mood states by correlating them with neural activity via intracranial electrodes. This could lead to better remote monitoring of mood in clinical and home settings.See study design
What are the potential side effects?
While specific side effects are not listed, intracranial electrode placement involves risks such as infection, bleeding, or damage to brain tissue which may result in neurological symptoms.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 65 years old.
Select...
I have been diagnosed with major depression currently.
Select...
I have no health issues preventing me from getting an electrode implant.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Quantitative Audio-Facial Change
Quantitative Mood Change
Secondary outcome measures
Correlation between Audio-Facial and Mood Change
Qualitative Mood Change

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Active Direct electrical stimulation (DES)Active Control1 Intervention
Intracranial electrodes will be used for the delivery of invasive brain stimulation.
Group II: Sham Direct electrical stimulation (DES)Placebo Group1 Intervention
Intracranial electrodes will be used for the delivery of invasive brain stimulation.

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,395 Previous Clinical Trials
17,341,340 Total Patients Enrolled
16 Trials studying Epilepsy
1,248 Patients Enrolled for Epilepsy

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it currently possible to join this clinical experiment?

"Unfortunately, this clinical trial is no longer recruiting patients. Initially posted in December 1st 2023 and last updated on the 4th of the same month, it has been superseded by 1110 other trials that are currently seeking candidates."

Answered by AI

Could I potentially be accepted into this research project?

"Criteria for inclusion in this clinical trial necessitates that applicants suffer from epilepsy and be within the specified age range. The researchers are seeking approximately 10 participants."

Answered by AI

Is this medical trial open to participants aged sixty and above?

"The bounds of eligibility for this medical trial are those aged 18 to 65. In addition, there are 220 trials aimed at people younger than the age of majority and 787 focused on seniors over the age of retirement."

Answered by AI
~7 spots leftby May 2025